Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer - Concepedia

Concepedia

Publication | Closed Access

Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer

31

Citations

13

References

2019

Year

Hibiki Udagawa, Hiroaki Akamatsu, Kentaro Tanaka, Masayuki Takeda, Shintaro Kanda, Keisuke Kirita, Shunsuke Teraoka, Kazuhiko Nakagawa, Yutaka Fujiwara, Ikuko Yasuda,

Japanese PatientsOncologyMedicinePathologyImmune Checkpoint InhibitorPharmacokinetics StudyBronchial NeoplasmCancer TreatmentPharmacologyRadiation OncologyLung CancerRovalpituzumab Tesirine

References

	Year	Citations

Page 1

Page 1